ProCure Proton Therapy Center Offers Non-Invasive Solution

ProCure Proton Therapy Center reports that Tom Corlett, a retired New Jersey resident, first learned of his brain tumor by accident, when sinus pain drove him to see his doctor. Several tests later, he was shocked to discover that it was not sinus pain but instead a golf-ball-sized meningioma brain tumor sitting right behind his nose.

As the tumor continued growing, Corlett braced himself for surgery, which he thought was the only viable option, although he was terrified of taking this invasive route.

But after more research, Corlett learned about a non-invasive option at ProCure Proton Therapy Center. Proton therapy is a highly advanced form of radiation treatment that, unlike standard radiation, safely and precisely destroys cancer cells while sparing surrounding healthy tissue.

In Corlett’s case, he chose ProCure because it effectively stopped the tumor from growing. “I had no residual effects from the procedure,” Corlett said. “Physically, I feel fine. I’m back to playing golf and chasing the grandkids around.”

Dr. Brian Chon, ProCure Proton Therapy Center Medical Director, said proton therapy’s precision makes it ideal for many types of cancers, including complex cases and recurrent tumors. Proton therapy can help preserve neurocognitive function by limiting doses to the normal, uninvolved brain when compared to X-ray based treatments.

“We are grateful to play a role in Tom’s journey,” Dr. Chon said. “Brain tumors can significantly impact quality of life, and they are sometimes near critical organs. This often makes proton therapy a good option.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.